Browsing by Yonsei Author : Rha, Sun Young

eperson profile image
Name:
Rha, Sun Young [라선영]
orcid http://orcid.org/0000-0002-2512-4531
Department :
College of Medicine (의과대학) - Dept. of Internal Medicine (내과학교실)
Scopus ID :
Scopus (7006023235)

Keyword Cloud

Researcher Network

Showing results 51 to 100 of 526

This table browses all dspace content
Issue DateTitleJournal Title
2022Early Tumor-Immune Microenvironmental Remodeling and Response to First-Line Fluoropyrimidine and Platinum Chemotherapy in Advanced Gastric Cancer CANCER DISCOVERY
2022The Essentials of Multiomics ONCOLOGIST
2022International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO-GC-1) ANNALS OF GASTROENTEROLOGICAL SURGERY
2022Multicenter phase Ib/II study of second-line trastuzumab, ramucirumab, and paclitaxel in patients with HER2-positive advanced gastric or gastroesophageal junction cancer: Updated HER-RAM study with biomarker analysisJOURNAL OF CLINICAL ONCOLOGY
2022Genomic profiling as a response predictor of second-line treatment in advanced gastric cancer patients: Post-hoc analyses of two phase Ib/II trialsJOURNAL OF CLINICAL ONCOLOGY
2022Efficacy and safety of lenvatinib (LEN) plus pembrolizumab (PEMBRO) versus sunitinib (SUN) in the East Asian subset of patients with advanced renal cell carcinoma (aRCC) from the phase 3 CLEAR trialJOURNAL OF CLINICAL ONCOLOGY
2022Dose-escalation and dose-expansion study of trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2+ gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03JOURNAL OF CLINICAL ONCOLOGY
2021Inhibition of the bromodomain and extra-terminal family of epigenetic regulators as a promising therapeutic approach for gastric cancerCELLULAR ONCOLOGY
2021Prognostic significance of T-cell-inflamed gene expression profile and PD-L1 expression in patients with esophageal cancer CANCER MEDICINE
2021Toward a Treatment Sequencing Strategy: A Systematic Review of Treatment Regimens in Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma ONCOLOGIST
2021Pemetrexed plus cisplatin in patients with previously treated advanced sarcoma: a multicenter, single-arm, phase II trial ESMO OPEN
2021Phase 2 study of TAS-117, an allosteric akt inhibitor in advanced solid tumors harboring phosphatidylinositol 3-kinase/v-akt murine thymoma viral oncogene homolog gene mutations INVESTIGATIONAL NEW DRUGS
2021Ramucirumab plus paclitaxel as second-line treatment in patients with advanced gastric or gastroesophageal junction adenocarcinoma: a nationwide real-world outcomes in Korea study (KCSG-ST19-16) THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
2021PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric CancerJOURNAL OF CLINICAL ONCOLOGY
2021SFRP4 drives invasion in gastric cancer and is an early predictor of recurrence GASTRIC CANCER
2021"3G" Trial: An RNA Editing Signature to Guide Gastric Cancer ChemotherapyCANCER RESEARCH
2021Development and validation of a serum microRNA biomarker panel for detecting gastric cancer in a high-risk population GUT
2021Detection of asymptomatic recurrence improves survival of gastric cancer patients CANCER MEDICINE
2021Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell CarcinomaNEW ENGLAND JOURNAL OF MEDICINE
2021Guidelines for Cancer Care during the COVID-19 Pandemic in South Korea CANCER RESEARCH AND TREATMENT
2021Stable Symptom Clusters and Evolving Symptom Networks in Relation to Chemotherapy CyclesJOURNAL OF PAIN AND SYMPTOM MANAGEMENT
2021Comparative efficacy and tolerability of third-line treatments for advanced gastric cancer: A systematic review with Bayesian network meta-analysisEUROPEAN JOURNAL OF CANCER
2021Antibody-Based Targeting of Interferon-Beta-1a Mutein in HER2-Positive Cancer Enhances Antitumor Effects Through Immune Responses and Direct Cell Killing FRONTIERS IN PHARMACOLOGY
2021p16 methylation is a potential predictive marker for abemaciclib sensitivity in gastric cancerBIOCHEMICAL PHARMACOLOGY
2020Transcriptome analysis of iBET-151, a BET inhibitor alone and in combination with paclitaxel in gastric cancer cells Genomics & Informatics
2020Cross-species chromatin interactions drive transcriptional rewiring in Epstein-Barr virus-positive gastric adenocarcinomaNATURE GENETICS
2020Scale-Up Evaluation of a Composite Tumor Marker Assay for the Early Detection of Renal Cell Carcinoma DIAGNOSTICS
2020Gene Expression Profiling Identifies Akt as a Target for Radiosensitization in Gastric Cancer Cells FRONTIERS IN ONCOLOGY
2020Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer MOLECULAR THERAPY-ONCOLYTICS
2020Phase I Escalation and Expansion Study of Bemarituzumab (FPA144) in Patients With Advanced Solid Tumors and FGFR2b-Selected Gastroesophageal Adenocarcinoma JOURNAL OF CLINICAL ONCOLOGY
2020Synergistic Antitumor Effects of Combined Treatment with HSP90 Inhibitor and PI3K/mTOR Dual Inhibitor in Cisplatin-Resistant Human Bladder Cancer Cells YONSEI MEDICAL JOURNAL
2020Development and evaluation of the Cancer Symptom Management System: Symptom Management Improves your LifE (SMILE)-a randomized controlled trialSUPPORTIVE CARE IN CANCER
2020Unmet needs in the physical and daily living domain mediates the influence of symptom experience on the quality of life of gastric cancer patientsSUPPORTIVE CARE IN CANCER
2019Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium EUROPEAN UROLOGY ONCOLOGY
2019Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationale FUTURE ONCOLOGY
2019Tumor microenvironment dictates regulatory T cell phenotype: Upregulated immune checkpoints reinforce suppressive function JOURNAL FOR IMMUNOTHERAPY OF CANCER
2019Mesothelin Expression Is a Predictive Factor for Peritoneal Recurrence in Curatively Resected Stage III Gastric CancerONCOLOGIST
2019Stability of symptom clusters and sentinel symptoms during the first two cycles of adjuvant chemotherapySUPPORTIVE CARE IN CANCER
2019A phase I/II study of poziotinib combined with paclitaxel and trastuzumab in patients with HER2-positive advanced gastric cancerGASTRIC CANCER
2019EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group BMC CANCER
2019Significance of Metabolic Tumor Volume and Total Lesion Glycolysis Measured Using ¹⁸F-FDG PET/CT in Locally Advanced and Metastatic Gallbladder Carcinoma YONSEI MEDICAL JOURNAL
2019Randomised phase II trial comparing four front-line doublets in Asian patients with metastatic gastric cancerEUROPEAN JOURNAL OF CANCER
2019Inhibiting casein kinase 2 overcomes paclitaxel resistance in gastric cancerGASTRIC CANCER
2019Comprehensive immune profiling and immune-monitoring using body fluid of patients with metastatic gastric cancer Journal for Immunotherapy of Cancer
2019Characteristics and Treatment Patterns of Patients with Advanced Soft Tissue Sarcoma in Korea CANCER RESEARCH AND TREATMENT
2019Temsirolimus in Asian Metastatic/Recurrent Non-clear Cell Renal Carcinoma CANCER RESEARCH AND TREATMENT
2019Behaviors and Attitudes toward the Use of Complementary and Alternative Medicine among Korean Cancer Patients Cancer Research and Treatment
2019Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue SarcomaOncology
2019Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial Cancer Research and Treatment
2019Landscape of Actionable Genetic Alterations Profiled from 1,071 Tumor Samples in Korean Cancer Patients Cancer Research and Treatment

Browse

Links